PMID: 42487672

Effects of combined metformin and cabergoline versus metformin alone on inflammatory markers in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial.

Hamad Inas Naser, Kadhim Sinaa Abdul Amir, Bassim Mohammad, Asma Swadi, Adnan Fawzi Hayder

Journal of medicine and life · 2026

Vol. 19, Issue 5, pp. 359-365

This entry links to third-party literature. For research use only.

HumansFemaleMetforminPolycystic Ovary SyndromeHyperprolactinemiaCabergolineDrug Therapy, CombinationBiomarkersErgolinesAdult

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.